The use of fecal microbiota, live-jslm (RBL; REBYOTA®) in the prevention of recurrent Clostridioides difficile infection ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

The evidence base on aetiology and treatment was small ... treatment facilities in St Louis. Mikton C. Grounds A. 2007 Vignette 1 (BPD): no sig diff in diagnosis PD. Vignette 2 (ASPD): More ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Some Nottinghamshire hospitals have faced more pressure and difficulty this winter than at any in point in the last 30 years, an NHS leader says.

Operator Good day, everyone and welcome to Pfizer's fourth-quarter 2024 earnings conference call. Today's call is being ...

Some of Hollywood's biggest kid actors descended on shocking downward spirals that saw them ultimately end up in legal ...

The Corvette team wanted to take the car from front- to mid-engine for decades before they got the budget to develop the 2020 ...

Dr Simon Roe, acting medical director for Sherwood Forest Hospitals NHS Trust, said the period between October and December last year had been the one of the hardest in his three decades in emergency ...

A study of 57,000 people in 21 countries finds that only 6.9 per cent who met criteria for a mental health or substance-use disorder received effective treatment. The biggest barrier to effective ...